Warthausen, Germany

Gu/ Nter Trummlitz

This inventor holds 3 USPTO granted patents. Top assignee: Dr. Karl Thomae Gmbh. Active years: 1984-1987.


% Patents Active = 100.0

Average Co-Inventor Count = 5.6

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1984-1987

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Gu/ Nter Trummlitz: Innovator in Pharmaceutical Chemistry

Introduction

Gu/ Nter Trummlitz is a notable inventor based in Warthausen, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative patents. With a total of 3 patents to his name, Trummlitz has focused on developing compounds that address critical health issues.

Latest Patents

One of his latest patents involves the compound (+)-6-chloro-5,10-dihydro-5-[(1-methyl-4-piperidinyl)-acetyl]-11H-dibenzo [b,e][1,4]diazepin-11-one. This compound is notable for its powerful activity against ulcers of the gastrointestinal tract. Another significant invention relates to thienobenzodiazepinones, which includes pharmaceutical compositions and methods for their use. These compounds are characterized by their unique chemical structures and potential therapeutic applications.

Career Highlights

Trummlitz has built a career centered around innovation in pharmaceutical development. His work has led to advancements in the treatment of gastrointestinal disorders, showcasing his commitment to improving patient outcomes through scientific research.

Collaborations

Throughout his career, Trummlitz has collaborated with esteemed colleagues such as Wolfhard Engel and Wolfgang Eberlein. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.

Conclusion

Gu/ Nter Trummlitz stands out as a dedicated inventor in the pharmaceutical industry. His innovative patents and collaborative efforts contribute significantly to advancements in medical science.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…